APA (7th ed.) Citation

Jensen, J. K., Zobel, E. H., Zobel, E. H., Scholten, B. J. v., Scholten, B. J. v., Curovic, V. R., . . . Ripa, R. S. (2021). Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Jensen, Jacob K., et al. Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial. Frontiers Media S.A, 2021.

MLA (8th ed.) Citation

Jensen, Jacob K., et al. Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial. Frontiers Media S.A, 2021.